Sign in

CIK 0001752828 · <br>Emerging growth company

Celularity Inc

Sign in to watch
Ticker
CELU
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
831702591
Phone
(908) 768-2170
Business address
170 PARK AVE, FLORHAM PARK, NJ, 07932
Former names
GX Acquisition Corp.
  1. PRE 14A Proxy Proxy Statement (Preliminary)
  2. 4 Shares withheld for taxes Pres, Functional Regeneration gave up 2,683 shares (to pay taxes)
  3. 4 Shares withheld for taxes See Remarks gave up 201 shares (to pay taxes)
  4. 4 Shares withheld for taxes Chief Executive Officer gave up 11,540 shares (to pay taxes)
  5. 4 Shares withheld for taxes Chief Financial Officer gave up 3,606 shares (to pay taxes)
  6. 4 Shares withheld for taxes See Remarks gave up 5,770 shares (to pay taxes)
  7. 4 Shares withheld for taxes See Remarks gave up 2,884 shares (to pay taxes)
  8. 424B5 Offering Prospectus
  9. 8-K Event Material agreement · Other events
  10. 10-K Report Annual Report
  11. 4 Shares withheld for taxes See Remarks gave up 2,170 shares (to pay taxes)
  12. 4 Grant or award Chief Executive Officer acquired 2,084,854 shares (grant or award)
  13. 8-K Event Material agreement · New debt or obligation · Unregistered share sale
  14. 8-K Event Other events
  15. 8-K Event Delisting notice
  16. 8-K Event Regulation FD disclosure
  17. 4 Grant or award See Remarks acquired 225,000 shares (grant or award)
  18. 4 Grant or award Senior Exec Vice President acquired 400,000 shares (grant or award)
  19. 4 Grant or award Chief Financial Officer acquired 250,000 shares (grant or award)
  20. 4 Grant or award See Remarks acquired 300,000 shares (grant or award)

Page 13 of 29 · 563 filings